期刊文献+

心肺复苏患者QT间期变化及其与恶性心律失常的关系 被引量:2

Study on QT interval change and its relationship with malignant arrhythmias in cardiopulmonary resuscitations
下载PDF
导出
摘要 目的:研究心肺复苏(CPR)者QT间期变化规律及其与恶性心律失常(MA)的关系,探讨胺碘酮干预继发性QT间期缩短患者,恢复自主循环(ROSC)后MA的发生率,为心脏骤停(CA)的防治提供依据。方法:回顾性分析60例CA行CPR、ROSC患者的心电图资料。结果:(1)CA前患者ROSC即刻的QT间期、QTc间期及JT间期、JTc间期较入院时明显缩短,差异有统计学意义(P<0.05)。(2)MA组和非MA组患者CA前和ROSC即刻QT间期及QTc间期均明显缩短,而MA组CA前及ROSC即刻的QT间期和QTc间期缩短更明显,差异有统计学意义(P<0.05)。(3)继发性QT间期缩短患者经胺碘酮治疗后,ROSC后MA的发生率无明显差异。结论:心肺复苏患者CA前及ROSC即刻QT间期缩短,MA患者QT间期缩短更明显,胺碘酮对继发性QT间期缩短患者ROSC后MA的发生无影响。 objective:To study QT interval change and its relationship with malignant arrhythmias(MA) in cardiopulmonary resuscitations;To explore the incidence of MA by amiodarone intervention after restoration of spontaneous circulation(ROSC) among patients with subsequent QT shortening,and provide evidence for the prevention and treatment of cardiac arrest(CA).Methods:Retrospective analysis of ECG data of 60 patients with CA underwent CPR and ROSC.Results:(1)QT interval,QTc interval,JT interval,and JTc interval were significantly shortened before CA and instantly after ROSC(P〈0.05).(2) For both MA group and non-MA group,QT interval and QTc interval were significantly shortened before CA and instantly after ROSC(P〈0.05).Moreover,the QT interval and QTc interval shortening were more obvious in group MA than in non-MA group.( 3)For patients with subsequent QT shortening,when treated with amiodarone,the incidence of MA after ROSC was not significantly reduced.Conclusion:QT intervals are significantly shortened before CA and instantly after ROSC,which is more obvious in patients with MA.Amiodarone has no effect on the occurrence of MA in patients with secondary QT interphase shorten after ROSC.
出处 《华夏医学》 CAS 2016年第1期30-32,共3页 Acta Medicinae Sinica
基金 桂林市科学研究与技术开发资助项目(20120121-1-8)
关键词 QT间期 心源性猝死 恶性心律失常 心肺复苏 QT interval sudden cardiac death malignant arrhythmias cardiopulmonary resuscitation
  • 相关文献

参考文献11

  • 1Turakhia M P. Sudden cardiac death and implantable car- dioverter- defibrillators [ J ].Am Fam Physician,2010,82 (11):1357-1366.
  • 2郭继鸿.中国心脏性猝死现状与防治[J].中国循环杂志,2013,28(5):323-326. 被引量:92
  • 3陈志坚.心室颤动的新概念[J].临床急诊杂志,2009,10(1):3-5. 被引量:3
  • 4Jeyaraj D,Haldar S M,Wan X,et al.Circadian rhythms gov- ern cardiac repolarization and arrhythmogenesis [ J ] .Na- ture,2012,483(7387): 96-99.
  • 5Algra A,Tijssen J G,Roelandt J R,et al.QT interval vari- ables from 24-Hour electrocardiography and the two Year risk of sudden death [ J ]. Br Heart J,1993,70(1):43-48.
  • 6Sugiyama H,Nakamura K,Morita H,et al.CirculatingKCNH2 current-activating factor in patients with heart failure and ventricular tachyarrhythmia [J].PloS One, 2011, 6(5): e19897.
  • 7Raschi E,Poluzzi E,Koci A,et al. QT-interval shortening in spontaneous reports submitted to the FDA:the need for con- sensus.Br J Clin Pharmaco [ J ] .2011,72:839-841.
  • 8Villafane J,Atallah J, Gollob M H, et al. Long-term follow- up of a pediatric cohort with short QT syndrome [ J ] .J Am Coll Cardiol,2013, 61(11):1183-1191.
  • 9Mazzanti A,Kanthan A,Monteforte N,et al.Novel insights in the natural history of Short QT Syndrome [ J ]. J Am Coll Cardiol, 2014, 63 ( 13 ) : 1300-1308.
  • 10洪葵,苏海,程晓曙,Ramon Brugada.短QT综合征的研究进展[J].中华心血管病杂志,2004,32(8):757-758. 被引量:6

二级参考文献19

  • 1郭成军,张英川,刘冰,郭晋萍,徐霞,裴莉,陈晖.心室颤动初始节律的动态心电图观察[J].中华心血管病杂志,2004,32(8):689-693. 被引量:23
  • 2WEVER E F, ROBLES D E, MEDINA E O. Sudden death in patients without structural heart disease[J]. J Am Coll Cardiol,2004,43:1137--1144.
  • 3MYERBURG R J, CASTELLANOS A. Cardiac ar rest and sudden cardiac death. In Braunwald's heart disease[J]. Philadelphia:Saunders Elsevier, 2008,8: 933--974.
  • 4Cardiac arrhythmia suppression trial (CAST) investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction[J]. N Engl J Med,1989,321:406--412.
  • 5The cardiac arrhythmia suppression Trial-Ⅱ investigators. Effect of antiarrhythmic agent moricizine on survival after myocardial infarction: the cardiac arrhythmia suppression Trial-Ⅱ [J]. N Engl J Med, 1992,327:223--227.
  • 6WALDO A L, CAMM A J, DERUYTER H, et al. Effect of d-sotalol on mortality in patients with left ven- tricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival with O- ral d-Sotalol[J]. Lancet, 1996,348 : 7 -- 12.
  • 7ZIPES D P, CAMM A J, BORGGREFE M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death[J]. Circulation, 2006, 114 : e385-- e484.
  • 8ANDERSON J L, HALLSTROM A P, EPSTEIN A E, et al. Design and results of the antiarrhythmics VS implantable defibrillators (AVID) registry. The AVID investigators[J]. Circulation, 1999,99 : 1692 -- 1699.
  • 9BOKHARI F, NEWMAN D, GREENE M, et al. Long term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the canadian implantable defibrillator study (CIDS) [J]. Circulation, 2004, 110 : 112--116.
  • 10Multicenter unsustained tachycardia trial investiga tors. Effect of implantable defibrillators on arrhyth mic events and mortality in the muhicenter unsus tained tachycardia trial [J]. Circulation, 2002, 106:233--238.

共引文献98

同被引文献12

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部